文献速递角膜与眼表疾病

干眼评估与管理(DREAM)研究中的性别差异与激素影响

Sex-related differences and hormonal effects in the Dry Eye Assessment and Management (DREAM) study.
PubMed 文献 · Br J Ophthalmol · 2023-12-18

DREAM研究比较了男性和女性、以及绝经前和绝经后女性之间的干眼体征与症状。女性体征较男性更重,绝经后女性体征较绝经前女性更重,但症状在各组间无显著差异。

要点

  • 女性Schirmer试验评分低于男性(9.27 vs 12.16,p<0.001),角膜染色评分更高(3.59 vs 2.70,p=0.006)。
  • 绝经后女性角膜染色、结膜染色、泪液渗透压、TBUT、睑板腺功能障碍及复合体征评分均差于绝经前女性。
  • 男女性别间及绝经前后女性间干眼症状评分均无显著差异(所有p≥0.08)。

核心结论

  • 在DREAM研究中,女性干眼体征较男性更严重,绝经后女性干眼体征较绝经前女性更严重。

研究设计与样本

  • DREAM研究纳入434名女性和101名男性,自报既往病史并在基线、6个月和12个月接受标准化干眼评估。

主要发现

  • 女性Schirmer试验评分低于男性(9.27 vs 12.16,p<0.001),角膜染色评分高于男性(3.59 vs 2.70,p=0.006),复合干眼体征评分差于男性(0.52 vs 0.40,p<0.001)。
  • 绝经后女性角膜染色评分高于绝经前女性(3.74 vs 2.58,p<0.001),结膜染色评分更高(2.80 vs 2.22,p<0.001),泪液渗透压更高(304 vs 299,p=0.004)。
  • 绝经后女性TBUT低于绝经前女性(3.37 vs 3.93,p=0.047),睑板腺功能障碍评分更差(3.05 vs 2.62,p=0.04),复合干眼体征评分更差(0.54 vs 0.42,p<0.001)。
  • 男女性别间及绝经前后女性间干眼症状均无显著差异(所有p≥0.08)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/AIMS: To compare dry eye disease (DED) signs and symptoms between men and women, as well as between premenopausal and postmenopausal women, in the Dry Eye Assessment and Management (DREAM) study. METHODS: 434 women and 101 men self-reported prior medical history and underwent a standardised DED assessment using the Ocular Surface Disease Index, Brief Pain Inventory, Tear Break-Up Time (TBUT)(s), Schirmer's test 2 (mm/5 min), National Eye Institute-graded lissamine conjunctival staining, corneal staining, meibomian gland dysfunction evaluation and tear osmolarity (mOsms/L) at baseline, 6 months and 12 months. Multivariable linear regression models were used to compare these scores. RESULTS: Women experienced significantly worse DED signs than men with lower Schirmer's test scores (9.27 vs 12.16; p<0.001), higher corneal staining scores (3.59 vs 2.70; p=0.006) and worse composite DED sign scores (0.52 vs 0.40; p<0.001). Postmenopausal women experienced significantly worse DED signs than premenopausal women with higher corneal staining scores (3.74 vs 2.58, p<0.001), higher conjunctival staining scores (2.80 vs 2.22, p<0.001), higher tear osmolarity (304 vs 299, p=0.004), lower TBUT (3.37 vs 3.93, p=0.047), worse meibomian gland dysfunction (3.05 vs 2.62, p=0.04) and worse composite DED sign scores (0.54 vs 0.42, p<0.001). There were no significant differences in DED symptoms between sex and between premenopausal and postmenopausal women (all p≥0.08). CONCLUSION: In the DREAM study, women experienced more severe DED signs than men. Further, postmenopausal women presented with more severe DED signs than premenopausal women. Elucidating these differences may improve DED diagnosis and provide future direction in understanding sex-related differences in DED. TRIAL REGISTRATION NUMBER: NCT02128763.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Zhao M, Yu Y, Roy NS, et al. Sex-related differences and hormonal effects in the Dry Eye Assessment and Management (DREAM) study. Br J Ophthalmol. 2023. PMID: 36575626. doi:10.1136/bjo-2022-322238

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。